Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Emerald BioStructure and SomaLogic collaborate on SOMAmers and small-molecule therapeutics

Sep. 7, 2010

MorphoSys and Absynth collaborate on research into infectious disease

Sep. 7, 2010

Stallergenes and Shionogi partner on two immunotherapy tablets

Sep. 7, 2010

Nabi enters agreement with Diosynth for manufacture of NicVAX nicotine vaccine

Sep. 7, 2010

MSD and Faes Farma to market sitagliptin and sitagliptin/metformin in Spain

Sep. 6, 2010

Ipsen gains rights to fipamezole outside of North America and Japan

Sep. 3, 2010

iBio, Fraunhofer and GE Healthcare to partner for iBioLaunch platform

Sep. 3, 2010

Orexigen and Takeda to co-commercialize Contrave in North America

Sep. 3, 2010

MorphoSys and Absynth partner for MRSA treatments

Sep. 3, 2010

HUYA and Sun Yat-sen University to develop novel drugs in China

Sep. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...